Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti‐allergic activity
- 1 February 1997
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 27 (2) , 182-191
- https://doi.org/10.1111/j.1365-2222.1997.tb00691.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- ICAM‐1/CD54 expression on conjunctival epithelium during pollen seasonAllergy, 1995
- The EyeAllergy, 1995
- Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposureJournal of Allergy and Clinical Immunology, 1994
- Interleukin‐8 is a potent eosinophil chemo‐attractantClinical and Experimental Allergy, 1994
- Inhibitory action of azelastine on cytokine production from human peripheral blood leukocytes in vitroLife Sciences, 1993
- Interleukin‐8 is a chemo‐attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjectsClinical and Experimental Allergy, 1993
- Allergic subjects express intercellular adhesion molecule — 1 (ICAMA or CD54) on epithelial cells of conjunctiva after allergen challengeJournal of Allergy and Clinical Immunology, 1993
- Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugsInflammation Research, 1985
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984